Used in pharmaceutical research as a potent inhibitor of Janus kinase (JAK) enzymes, particularly JAK1 and JAK2. This compound shows promise in the treatment of autoimmune and inflammatory diseases such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease. Its structure allows selective targeting of JAK signaling pathways, helping to modulate immune response with reduced off-target effects. It is also investigated for potential use in myeloproliferative disorders due to its ability to interfere with abnormal cell signaling in hematopoietic cells.